Genesco Inc. is projected to rise to $43.35 by 2027, a +17% move from its current price of $37.18. GCO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $36.24 | $37.17 | $38.13 | -0.01% |
| May 30 | $35.86 | $37.17 | $38.53 | -0.03% |
| May 31 | $35.56 | $37.16 | $38.84 | -0.04% |
| Jun 1 | $35.32 | $37.16 | $39.09 | -0.06% |
| Jun 2 | $35.10 | $37.15 | $39.32 | -0.07% |
| Jun 3 | $34.91 | $37.15 | $39.53 | -0.09% |
| Jun 4 | $34.73 | $37.14 | $39.72 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $34.73 | $37.14 | $39.72 | -0.10% |
| Week 2 | $33.74 | $37.10 | $40.80 | -0.21% |
| Week 3 | $32.99 | $37.06 | $41.64 | -0.31% |
| Week 4 | $32.37 | $37.02 | $42.35 | -0.42% |
| Week 5 | $31.82 | $36.99 | $42.99 | -0.52% |
| Week 6 | $31.34 | $36.95 | $43.56 | -0.62% |
| Week 7 | $30.90 | $36.91 | $44.09 | -0.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genesco Inc. is a retailer and wholesaler of footwear, apparel, and accessories. It operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands Group.
The Journeys Group segment offers footwear and accessories for young men, women, and children through the Journeys, Journeys Kidz, and Little Burgundy retail chains, as well as through e-commerce operations. The Schuh Group segment operates Schuh retail footwear stores that offer casual and athletic footwear, as well as sells footwear through e-commerce. The Johnston & Murphy Group segment is involved in the retail and e-commerce operations; and wholesale distribution of footwear, apparel, and accessories primarily for men.
The Genesco Brands Group segment markets footwear under the Levi's, Dockers, and other brands. The company provides its products through catalogs and e-commerce websites, including journeys.com, journeyskidz.com, journeys.ca, schuh.co.uk, schuh.ie, schuh.eu, littleburgundyshoes.com, johnstonmurphy.com, and nashvilleshoewarehouse.com. It operates retail stores in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland primarily under the Journeys, Journeys Kidz, Schuh, Little Burgundy, and Johnston & Murphy brands.
Genesco Inc. was incorporated in 1934 and is headquartered in Nashville, Tennessee.
Genesco Inc. (GCO) is a consumer cyclical company that operates as a retailer and wholesaler of footwear, apparel, and accessories. The stock is currently trading at $37.02 per share with a market capitalization of $401.97M and is ranked 3223.
It is positioned in the consumer cyclicals space and maintains a multi-segment footprint across retail and e-commerce channels. The provided forecast data indicate a bullish path over the long term, with the average price expected to rise from the current level toward higher targets by 2030, 2040, and 2050. Overall, the outlook suggests meaningful upside potential but remains contingent on market conditions and other uncertainties.
A major floor 33.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.5% away) — a breakout level to watch.
A major ceiling 10.5% above — clearing it would confirm fresh momentum.
Key GCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $36.13 | Buy | $36.19 | Buy |
| MA 10 | $34.21 | Buy | $35.15 | Buy |
| MA 20 | $34.13 | Buy | $34.38 | Buy |
| MA 50 | $32.20 | Buy | $32.74 | Buy |
| MA 100 | $30.68 | Buy | $31.23 | Buy |
| MA 200 | $30.01 | Buy | $29.99 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.62 | Neutral |
| Stoch RSI (14) | 94.97 | Sell |
| CCI (20) | 136.21 | Buy |
| Williams %R (14) | -3.53 | Info |
| MACD (12,26,9) | 0.35 | Buy |
| ROC (12) | 6.56 | Buy |
| Bollinger %B (20,2) | 0.94 | Neutral |
| Stochastic %K (14) | 96.47 | Sell |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 1.79 | Buy |
| Ultimate (7,14,28) | 72.50 | Sell |
| Momentum (10) | 5.47 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 38.18 | Sell |
| ADX (14) | 20.24 | Buy |
| ATR (14) | 0.85 | Info |
The 30-day technical picture is bullish, with positive near-term momentum. RSI14 sits at 60, and the stock trades above both the SMA50 ($31.73) and the SMA200 ($29.88), indicating constructive trend footing. Near-term support is identified at $31.71, while resistance is at $37.02, framing a positive setup as the price approaches the immediate ceiling.
The 30-day price range spans from $30.99 to $44.22, signaling room for upside within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $24.73 | $37.18 | $51.65 | 0% | Neutral | |
| $34.61 | $43.35 | $57.37 | +17% | Neutral | |
| $37.37 | $47.99 | $65.68 | +29% | Bullish | |
| $49.61 | $65.06 | $91.45 | +75% | Bullish | |
| $56.21 | $75.10 | $107.96 | +102% | Bullish | |
| $61.33 | $83.34 | $122.20 | +124% | Bullish | |
| $65.96 | $91.05 | $135.90 | +145% | Bullish | |
| $65.36 | $91.56 | $138.89 | +146% | Bullish | |
| $73.82 | $104.87 | $161.46 | +182% | Bullish | |
| $84.57 | $121.76 | $190.09 | +227% | Bullish | |
| $115.07 | $176.07 | $291.35 | +374% | Bullish | |
| $256.86 | $436.07 | $785.89 | +10.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $24.73 | $37.18 | $43.66 | +0.00% |
| June 2026 | $31.32 | $36.72 | $44.04 | -1.23% |
| July 2026 | $31.03 | $36.68 | $44.54 | -0.12% |
| August 2026 | $32.09 | $38.16 | $46.80 | +4.04% |
| September 2026 | $32.53 | $38.88 | $48.05 | +1.88% |
| October 2026 | $32.19 | $38.65 | $48.11 | -0.58% |
| November 2026 | $32.87 | $39.63 | $49.64 | +2.53% |
| December 2026 | $33.87 | $41.00 | $51.65 | +3.45% |
Click any year to see its month-by-month GCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Genesco Inc.'s 2026 outlook centres on $37.18, within a $24.73 to $51.65 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, GCO could reach as high as $57.37, with a base case around $43.35 and support toward $34.61 — roughly +17% from $37.18. A consolidation phase looks the most probable path here.
Expect GCO to range from $37.37 to $65.68 through 2028. The $47.99 average target implies a +29% move from current prices. That is up +11% on the projected 2027 average. Momentum favours further upside here.
The GCO price prediction for 2029 points to an average of $65.06 (low $49.61, high $91.45) — a potential gain of +75% on today's $37.18. Buyers look set to stay in control over this stretch.
In 2030, GCO is projected to trade between $56.21 and $107.96, averaging $75.10 — a potential gain of +102% from today's $37.18. That is up +15% on the projected 2029 average. Momentum favours further upside here.
Genesco Inc.'s 2031 outlook centres on $83.34, within a $61.33 to $122.20 range. That is up +11% on the projected 2030 average. That marks a +124% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, GCO could reach as high as $135.90, with a base case around $91.05 and support toward $65.96 — roughly +145% from $37.18. Momentum favours further upside here.
Expect GCO to range from $65.36 to $138.89 through 2033. The $91.56 average target implies a +146% move from current prices. That is up +1% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The GCO price prediction for 2034 points to an average of $104.87 (low $73.82, high $161.46) — a potential gain of +182% on today's $37.18. Momentum favours further upside here.
In 2035, GCO is projected to trade between $84.57 and $190.09, averaging $121.76 — a potential gain of +227% from today's $37.18. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Genesco Inc.'s 2040 outlook centres on $176.07, within a $115.07 to $291.35 range. That is up +45% on the projected 2035 average. That marks a +374% change versus current levels. Momentum favours further upside here.
By 2050, GCO could reach as high as $785.89, with a base case around $436.07 and support toward $256.86 — roughly +10.7x from $37.18. Buyers look set to stay in control over this stretch.
Investing $1,000 in GCO today (≈ 26.896181 GCO) could be worth
$11,728.6
+$10,728.6 (+1073%) by 2050 · US Dollar
Based on the average projected GCO price of $436.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GCOwould be worth at today's price.
$1,000 invested in GCO on May 27, 2025 (≈ 45.745653 GCO) would be worth
$1,700.82
+$700.82 (+70.1%) today · 1.70× · US Dollar
Based on a GCO entry price of $21.86 vs. today's $37.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33.38 | $1,113.84 | +11.4% |
| 1 month ago | $35.4 | $1,050.28 | +5.0% |
| 3 months ago | $27.51 | $1,351.51 | +35.2% |
| 6 months ago | $35.85 | $1,037.1 | +3.7% |
| 1 year ago | $21.86 | $1,700.82 | +70.1% |
| All time (5.0y) ago | $58.07 | $640.26 | -36.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GCO forecast.
Our base-case forecast reaches $74.00 around 2030.
Implied market cap at $74.00: $803.51M
The multi-year forecast shows a clear bullish trajectory beyond 2025. For 2030, the min price is $57.48, the avg is $77.58, the max is $112.86, with an ROI of 109.5 and a bullish sentiment. By 2040, the min rises to $120.49, the avg to $188.18, the max to $317.07, with an ROI of 408.3 and a bullish sentiment.
In 2050, the min is $270.49, the avg $472.94, the max $870.84, with an ROI of 1177.5 and a bullish sentiment. These figures point to substantial long-term upside, tempered by the usual uncertainties around market performance and execution. The forecast consistently marks sentiment as BULLISH from 2028 onward, supporting a rising trajectory across later years, but it remains essential to recognize that these are estimates, not guarantees, of future results and are subject to market conditions and other risk factors.
Tap a question to reveal the answer.
2030 min $57.48, avg $77.58, max $112.86, ROI 109.5, sentiment BULLISH.
Forecasts show a bullish trajectory in later years with average prices rising to $188.18 by 2040 and to $472.94 by 2050, with ROI up to 1177.5, but these are estimates and not guarantees.
Yes—the 2026 forecast lists max $52.07, with min $24.73 and avg $37.02, and ROI 0; sentiment NEUTRAL.
2040 min $120.49, avg $188.18, max $317.07, ROI 408.3, sentiment BULLISH.
Current price $37.02; Market cap $401.97M; Rank 3223.
Genesco Inc. Community Discussion
0Share your Genesco Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.